These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 34138988)
61. Outcomes after implantation of partial-support left ventricular assist devices in inotropic-dependent patients: Do we still need full-support assist devices? Sabashnikov A; Popov AF; Bowles CT; Mohite PN; Weymann A; Hards R; Hedger M; Wittwer T; Wippermann J; Wahlers T; Schoendube FA; Simon AR J Thorac Cardiovasc Surg; 2014 Sep; 148(3):1115-21; discussion 1021-2. PubMed ID: 25129605 [TBL] [Abstract][Full Text] [Related]
62. Hemodynamic parameters at rest predicting exercise capacity in patients supported with left ventricular assist device. Kato H; Iwahana T; Ono R; Okada S; Matsumiya G; Kobayashi Y J Artif Organs; 2024 Mar; 27(1):7-14. PubMed ID: 36933087 [TBL] [Abstract][Full Text] [Related]
63. Tunneling a Pulmonary Artery Graft: A Simplified Way to Insert and Remove a Temporary Right Ventricular Assist Device. Saxena P; Marasco SF Tex Heart Inst J; 2015 Dec; 42(6):540-2. PubMed ID: 26664306 [TBL] [Abstract][Full Text] [Related]
64. It keeps on turning: Effects of prolonged long-term left ventricular assist device support as a bridge to heart transplantation. Schmack B; Grossekettler L; Zeriouh M; Weymann A; Mohite P; Koch A; Ruhparwar A; Simon AR; Sabashnikov A; Popov AF Int J Artif Organs; 2019 Feb; 42(2):65-71. PubMed ID: 30580668 [TBL] [Abstract][Full Text] [Related]
65. Sleeping prone with a left ventricular assist device: Dream or reality? Tsang DC; Kellner M; Thomas M; Araj FG Heart Lung; 2022; 56():57-61. PubMed ID: 35753119 [TBL] [Abstract][Full Text] [Related]
66. Significance of Residual Mitral Regurgitation After Continuous Flow Left Ventricular Assist Device Implantation. Kassis H; Cherukuri K; Agarwal R; Kanwar M; Elapavaluru S; Sokos GG; Moraca RJ; Bailey SH; Murali S; Benza RL; Raina A JACC Heart Fail; 2017 Feb; 5(2):81-88. PubMed ID: 28017353 [TBL] [Abstract][Full Text] [Related]
69. Prognostic value of TAPSE/PASP ratio in right ventricular failure after left ventricular assist device implantation: Experience from a tertiary center. Sert S; Selçuk N; Yıldırımtürk Ö; Orhan G Turk Gogus Kalp Damar Cerrahisi Derg; 2022 Jul; 30(3):334-343. PubMed ID: 36303699 [TBL] [Abstract][Full Text] [Related]
70. Successful Liver And Kidney Transplantations From A Donor With Left Ventricular Assist Device. Sahinturk H; Kaya D; Ersoy O; Zeyneloglu P; Haberal M Exp Clin Transplant; 2021 May; 19(5):497-500. PubMed ID: 32778013 [TBL] [Abstract][Full Text] [Related]
71. Protect right: right ventricular failure prevention strategy for left ventricular assist device implantation. Kawabori M; Nordan T; Kapur NK; Couper GS Eur J Cardiothorac Surg; 2021 May; 59(5):1128-1130. PubMed ID: 33236106 [TBL] [Abstract][Full Text] [Related]
72. Prediction of acute kidney injury after left ventricular assist device implantation: Evaluation of clinical risk scores. Pilarczyk K; Carstens H; Papathanasiou M; Luedike P; Koch A; Jakob H; Kamler M; Pizanis N Artif Organs; 2020 Feb; 44(2):162-173. PubMed ID: 31361341 [TBL] [Abstract][Full Text] [Related]
73. Assessment of right ventricular dysfunction predictors before the implantation of a left ventricular assist device in end-stage heart failure patients using echocardiographic measures (ARVADE): Combination of left and right ventricular echocardiographic variables. Aissaoui N; Salem JE; Paluszkiewicz L; Morshuis M; Guerot E; Gorria GM; Fagon JY; Gummert J; Diebold B Arch Cardiovasc Dis; 2015 May; 108(5):300-9. PubMed ID: 25863429 [TBL] [Abstract][Full Text] [Related]
74. Perioperative interventions for the prevention of surgical wound infection in adult patients undergoing left ventricular assist devices implantation: A scoping review. Brandão SMG; Urasaki MBM; Lemos DMP; Matos LN; Takahashi M; Nogueira PC; de Gouveia Santos VLC Intensive Crit Care Nurs; 2024 Jun; 82():103658. PubMed ID: 38431985 [TBL] [Abstract][Full Text] [Related]
75. Use of a pulsatile right ventricular assist device and continuous arteriovenous hemodialysis in a 57-year-old man with a pulsatile left ventricular assist device. Chen JM; Levin HR; Catanese KA; Sistino JJ; Landry DW; Rose EA; Oz MC J Heart Lung Transplant; 1995; 14(1 Pt 1):186-91. PubMed ID: 7727468 [TBL] [Abstract][Full Text] [Related]
77. [Early results of left ventricular assist device implantation for the treatment of heart failure]. Chen LW; Wu QS; Dai XF; Dong Y; Li QZ; Fang GH; Zhang GC Zhonghua Yi Xue Za Zhi; 2023 Mar; 103(12):920-923. PubMed ID: 36973220 [TBL] [Abstract][Full Text] [Related]
78. Optimization with levosimendan improves outcomes after left ventricular assist device implantation. Kocabeyoglu SS; Kervan U; Sert DE; Karahan M; Aygun E; Beyazal OF; Unal EU; Akin Y; Demirkan B; Pac M Eur J Cardiothorac Surg; 2020 Jan; 57(1):176-182. PubMed ID: 31155645 [TBL] [Abstract][Full Text] [Related]
79. Early decision for a left ventricular assist device implantation is necessary for patients with modifier A. Imamura T; Kinugawa K; Shiga T; Endo M; Inaba T; Maki H; Hatano M; Imai Y; Yao A; Hirata Y; Nishimura T; Kyo S; Ono M; Nagai R J Artif Organs; 2012 Sep; 15(3):301-4. PubMed ID: 22527979 [TBL] [Abstract][Full Text] [Related]